Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry Elliott

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 26, 2016
Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargementGiuseppe Limongelli, Daniele Masarone, Giulia Frisso, et al.
Journal of Cardiovascular Echography|April 23, 2019
Left Atrial Volume during Stress Is Associated with Increased Risk of Arrhythmias in Patients with Hypertrophic CardiomyopathyGiuseppe Limongelli, Vincenzo Fioretti, Marco Di Maio, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|December 10, 2024
Key priorities for the implementation of the 2023 ESC Guidelines for the Management of Cardiomyopathies in low resource settingsRuxandra Jurcut, Roberto Barriales-Villa, Elena Biagini, et al.
Lancet (London, England)|May 18, 2021
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trialJohn A Spertus, Jennifer T Fine, Perry Elliott, et al.
American Heart Journal|May 4, 2010
Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacityKhalid Abozguia, Ganesh Nallur-Shivu, Thanh T Phan, et al.
Journal of Inherited Metabolic Disease|October 9, 2016
Cardiomyopathy as presenting sign of glycogenin-1 deficiency-report of three cases and review of the literatureCarola Hedberg-Oldfors, Emma Glamuzina, Peter Ruygrok, et al.
Heart (British Cardiac Society)|July 16, 2011
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathyConstantinos O'Mahony, Pier D Lambiase, Giovanni Quarta, et al.
Cardiology in the Young|September 9, 2015
Psychosocial adjustment and quality of life in children undergoing screening in a specialist paediatric hypertrophic cardiomyopathy clinicAdriani Spanaki, Sara O'Curry, Jasmine Winter-Beatty, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 13, 2019
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisalFrancesco Pelliccia, Giampaolo Niccoli, Felice Gragnano, et al.
JAMA Cardiology|November 15, 2023
Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical TrialSanjiv J Shah, Nowell Fine, Pablo Garcia-Pavia, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 26, 2016
Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargementGiuseppe Limongelli, Daniele Masarone, Giulia Frisso, et al.
Journal of Cardiovascular Echography|April 23, 2019
Left Atrial Volume during Stress Is Associated with Increased Risk of Arrhythmias in Patients with Hypertrophic CardiomyopathyGiuseppe Limongelli, Vincenzo Fioretti, Marco Di Maio, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|December 10, 2024
Key priorities for the implementation of the 2023 ESC Guidelines for the Management of Cardiomyopathies in low resource settingsRuxandra Jurcut, Roberto Barriales-Villa, Elena Biagini, et al.
Lancet (London, England)|May 18, 2021
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trialJohn A Spertus, Jennifer T Fine, Perry Elliott, et al.
American Heart Journal|May 4, 2010
Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacityKhalid Abozguia, Ganesh Nallur-Shivu, Thanh T Phan, et al.
Journal of Inherited Metabolic Disease|October 9, 2016
Cardiomyopathy as presenting sign of glycogenin-1 deficiency-report of three cases and review of the literatureCarola Hedberg-Oldfors, Emma Glamuzina, Peter Ruygrok, et al.
Heart (British Cardiac Society)|July 16, 2011
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathyConstantinos O'Mahony, Pier D Lambiase, Giovanni Quarta, et al.
Cardiology in the Young|September 9, 2015
Psychosocial adjustment and quality of life in children undergoing screening in a specialist paediatric hypertrophic cardiomyopathy clinicAdriani Spanaki, Sara O'Curry, Jasmine Winter-Beatty, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 13, 2019
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisalFrancesco Pelliccia, Giampaolo Niccoli, Felice Gragnano, et al.
JAMA Cardiology|November 15, 2023
Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical TrialSanjiv J Shah, Nowell Fine, Pablo Garcia-Pavia, et al.
Pageof 16